SCHEMBL6746658

SCHEMBL6746658

COc1ccc(O)c(C=NNC(=N)N)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.57
KMT2A Q03164 7/20 0.53
MEN1 O00255 5/20 0.53
POLB P06746 4/20 0.53
ALPL P05186 1/20 0.53
ALPI P09923 1/20 0.53
ALPG P10696 1/20 0.53
MAPT P10636 4/20 0.52
KDM4E B2RXH2 4/20 0.52
GAA P10253 3/20 0.52
ALDH1A1 P00352 3/20 0.52
MGAM O43451 2/20 0.52
SI P14410 2/20 0.52
MGAM2 Q2M2H8 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
HTT P42858 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CA2 P00918 3/20 0.50
ERN1 O75460 1/20 0.50
ATM Q13315 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746656 1.00 ADORA2A (0.57) ADORA2AKMT2AMEN1POLBALPL
Hydrochloric Acid SCHEMBL6742966 0.99 ADORA2A (0.56) ADORA2AKMT2AMEN1POLBALPL
Hydrochloric Acid SCHEMBL6742974 0.99 ADORA2A (0.56) ADORA2AKMT2AMEN1POLBALPL
SCHEMBL6740126 0.89 ADORA2A (0.57) ADORA2AKMT2AMEN1POLBALPL
SCHEMBL6740122 0.89 ADORA2A (0.57) ADORA2AKMT2AMEN1POLBALPL
Hydrochloric Acid SCHEMBL6743487 0.87 ADORA2A (0.56) ADORA2AKMT2AMEN1POLBALPL
Hydrochloric Acid SCHEMBL6743491 0.87 ADORA2A (0.56) ADORA2AKMT2AMEN1POLBALPL
SCHEMBL7748706 0.86 KDM4E (0.53) KMT2AMEN1POLBMAPTKDM4E
SCHEMBL7748711 0.86 KDM4E (0.53) KMT2AMEN1POLBMAPTKDM4E
Hydrochloric Acid SCHEMBL5702989 0.84 KDM4E (0.52) KMT2AMEN1POLBMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770202-B1 Porous membrane PALL CORPORATION 2004-08-03 US claimed
US-20030186993-A1 Anti-malarial compounds, compositions and methods KENNETH S. WARREN INSTITUTE 2003-10-02 US claimed
US-6689777-B2 DEPOLYMERIZING HEMOZOIN USING 2-IMINO-NAPHTHO(1,2-D)THIAZOL-5-OL DERIVATIVES KENNETH S. WARREN INSTITUTE 2004-02-10 US disclosed
US-20030186993-A1 Anti-malarial compounds, compositions and methods KENNETH S. WARREN INSTITUTE 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186993-A1 Anti-malarial compounds, compositions and methods TYR, CRYZ, RHOT2 ADORA2A 4670/4885KMT2A 2497/4885MEN1 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.